These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 10247077)

  • 1. Drug Enforcement Administration--Records and reports of registrants; central recordkeeping permits. Final rule.
    Fed Regist; 1980 Jul; 45(128 Pt 1):44266-7. PubMed ID: 10247077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prescriptions for Schedule II controlled substances: Drug Enforcement Administration, Justice. Notice of proposed rulemaking.
    Fed Regist; 1980 Apr; 45(70):24199-200. PubMed ID: 10246081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recordkeeping and reporting requirements for drug products containing gamma-hydroxybutyric acid (GHB). Final rule.
    Drug Enforcement Administration (DEA), Justice
    Fed Regist; 2005 Jan; 70(2):291-4. PubMed ID: 15630794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recordkeeping and reporting under Title VII and the ADA--EEOC. Final rule.
    Fed Regist; 1991 Jul; 56(144):35753-6. PubMed ID: 10170777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health Care Financing Administration--Medicaid provider records and grants to Professional Standard Review Organizations: technical amendments. Final regulations.
    Fed Regist; 1980 May; 45(92):30634-5. PubMed ID: 10324769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug Enforcement Administration--controlled substances in emergency kits for long term care facilities. Statement of policy.
    Fed Regist; 1980 Apr; 45(70):24128. PubMed ID: 10246080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exemption of chemical mixtures. Final rule.
    Drug Enforcement Administration (DEA), U.S. Department of Justice
    Fed Regist; 2007 Mar; 72(47):10925-8. PubMed ID: 17450656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Occupational injury and illness recording and reporting requirements. Occupational Safety and Health Administration (OSHA), U.S. Department of Labor. Final rule.
    Fed Regist; 2001 Jan; 66(13):5916-6135. PubMed ID: 11503778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medicare/Medicaid program; revisions in reporting, recordkeeping, and other requirements--HCFA. Final rule.
    Fed Regist; 1988 Apr; 53(70):12010-6. PubMed ID: 10302338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uniform reporting systems for health services facilities and organizations: proposed rule.
    Fed Regist; 1979 Jan; 44(16):4741-4. PubMed ID: 10297326
    [No Abstract]   [Full Text] [Related]  

  • 11. Medicaid program; time limitation on recordkeeping requirements under the drug rebate program. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2004 Nov; 69(227):68815-8. PubMed ID: 15565749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prescriptions; dispensing controlled substances in institutional practitioner emergency rooms--Drug Enforcement Administration, Justice. Withdrawal of proposed rule.
    Fed Regist; 1983 Jun; 48(125):29713-4. PubMed ID: 10261481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specialized forms promote regulatory compliance.
    Pomeroy D
    Provider; 1990 Sep; 16(9):37-8. PubMed ID: 10106222
    [No Abstract]   [Full Text] [Related]  

  • 14. Current good tissue practice for human cell, tissue, and cellular and tissue-based product establishments; inspection and enforcement. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2004 Nov; 69(226):68611-88. PubMed ID: 15562555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exemption from import/export requirements for personal medical use. Final rule.
    Drug Enforcement Administration (DEA), Department of Justice
    Fed Regist; 2004 Sep; 69(177):55343-7. PubMed ID: 15366181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prescriptions; requirements clarification--Drug Enforcement Administration (DEA). Final rule.
    Fed Regist; 1991 Jun; 56(106):25025-7. PubMed ID: 10111144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventing the accumulation of surplus controlled substances at long term care facilities. Final rule.
    Drug Enforcement Administration (DEA), Justice
    Fed Regist; 2005 May; 70(92):25462-6. PubMed ID: 15892213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Departures from manufacturer's instructions; elimination of recordkeeping requirements--NRC. Final rule.
    Fed Regist; 1992 Oct; 57(192):45566-8. PubMed ID: 10121203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes to patient limitation for dispensing or prescribing approved narcotic controlled substances for maintenance or detoxification treatment by qualified individual practitioners. Final rule.
    Drug Enforcement Administration (DEA), Justice
    Fed Regist; 2008 May; 73(100):29685-8. PubMed ID: 18605404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clarification of registration requirements for individual practitioners. Final rule.
    Drug Enforcement Administration (DEA), Department of Justice
    Fed Regist; 2006 Dec; 71(231):69478-80. PubMed ID: 17171847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.